Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Public ClinicalTrials.gov record NCT05245500. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1 Multiple Expansion Cohort Trial of MRTX1719 in Patients With Advanced Solid Tumors With Homozygous MTAP Deletion
Study identification
- NCT ID
- NCT05245500
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 336 participants
Conditions and interventions
Conditions
Interventions
- MRTX1719 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 8, 2022
- Primary completion
- Dec 9, 2027
- Completion
- Dec 9, 2027
- Last update posted
- Dec 4, 2025
2022 – 2027
United States locations
- U.S. sites
- 24
- U.S. states
- 15
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic | Phoenix | Arizona | 85054-4502 | Recruiting |
| Sarah Cannon Research Institute (SCRI) - HealthONE Location | Denver | Colorado | 80218-1238 | Recruiting |
| Rocky Mountain Cancer Centers, LLP - Oncology | Lone Tree | Colorado | 80124 | Recruiting |
| Mayo Clinic | Jacksonville | Florida | 32224 | Recruiting |
| Sarah Cannon Research Institute at Florida Cancer Specialists | Orlando | Florida | 32827 | Recruiting |
| Local Institution - 124 | Chicago | Illinois | 60637 | Withdrawn |
| Dana-Farber Cancer Institute | Brookline | Massachusetts | 02251 | Recruiting |
| Cancer and Hematology Centers of Western Michigan | Norton Shores | Michigan | 49444 | Recruiting |
| Mayo Clinic | Rochester | Minnesota | 55905 | Recruiting |
| Rutgers Cancer Institute of New Jersey | New Brunswick | New Jersey | 08901 | Recruiting |
| Local Institution - 129 | Mineola | New York | 11501 | Not yet recruiting |
| David H Koch, Memorial Sloan Kettering Cancer Center | New York | New York | 10021 | Recruiting |
| New york cancer and blood specialists - Oncology | Port Jefferson Station | New York | 11776 | Recruiting |
| University of North Carolina - Gastroenterology and Hepatology | Chapel Hill | North Carolina | 27599 | Recruiting |
| University of North Carolina | Chapel Hill | North Carolina | 27599 | Recruiting |
| Vanderbilt - Ingram Cancer Center | Nashville | Tennessee | 37232-5505 | Recruiting |
| Ut Southwestern | Dallas | Texas | 75235 | Recruiting |
| Texas Oncology - DFW | Fort Worth | Texas | 76104 | Recruiting |
| MDACC | Houston | Texas | 77030 | Recruiting |
| South Texas Accelerated Research Therapeutics | San Antonio | Texas | 78229 | Recruiting |
| Texas Oncology, P.A. - Oncology | Tyler | Texas | 78503 | Recruiting |
| Virginia Cancer Specialists, PC | Fairfax | Virginia | 22031 | Recruiting |
| Local Institution - 134 | Seattle | Washington | 98109 | Withdrawn |
| Local Institution - 108 | Milwaukee | Wisconsin | 53226 | Completed |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05245500, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 4, 2025 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05245500 live on ClinicalTrials.gov.